A novel complement inhibitor sMAP‐FH targeting both the lectin and alternative complement pathways-Reference-Cited by-同舟云学术

A novel complement inhibitor sMAP‐FH targeting both the lectin and alternative complement pathways

Published:2020-03-26 Issue:5 Volume:34 Page:6598-6612
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Takasumi Mika¹²,Omori Tomoko¹,Machida Takeshi¹,Ishida Yumi¹,Hayashi Manabu¹²,Suzuki Toshiyuki³,Homma Yoshimi³,Endo Yuichi¹,Takahashi Minoru¹,Ohira Hiromasa²,Fujita Teizo⁴,Sekine Hideharu¹

Affiliation:

1. Department of Immunology Fukushima Medical University School of Medicine Fukushima‐City Japan

2. Department of Gastroenterology Fukushima Medical University School of Medicine Fukushima‐City Japan

3. Department of Biomolecular Science Fukushima Medical University School of Medicine Fukushima‐City Japan

4. Fukushima Prefectural General Hygiene Institute Fukushima‐City Japan

Funder

Curadim Pharma Co., Ltd.

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201902475R

Reference41 articles.

1. Complement: a key system for immune surveillance and homeostasis

2. Complement

3. Complement

4. Evolution of the lectin–complement pathway and its role in innate immunity

5. Isolation and characterization of a mannan-binding protein from rabbit liver

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complement system: A key player in the host response to infections;European Journal of Immunology;2024-08-27

2. The human factor H protein family – an update;Frontiers in Immunology;2024-02-12

3. Complement in human disease: approved and up-and-coming therapeutics;The Lancet;2024-01

4. MAP‐2:CD55 chimeric construct effectively modulates complement activation;The FASEB Journal;2023-10-12

5. Association of the Mannose-Binding Lectin 2 BB Genotype with COVID-19-Related Mortality;Life;2023-01-30